Vivani Medical Warrants
VANIW
VANIW was delisted on the 8th of September, 2022.
8 hedge funds and large institutions have $2.86M invested in Vivani Medical Warrants in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $8.66K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 2 |
Anson Funds Management
Dallas,
Texas
|
-$1.53K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.09K |
| 4 |
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$1K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$36 |
VANIW Hedge Fund Activity: Q2 2018 in Review
8 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical Warrants (VANIW) for Q2 2018, worth a combined $2.86M — down 14% from $3.34M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VANIW and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $5K sold.
- 8 institutional investors held Vivani Medical Warrants (VANIW) as of Q2 2018, down from 9 in Q1 2018.
- Funds reported $2.86M of Vivani Medical Warrants stock for Q2 2018, down 14% quarter-over-quarter.
- 1 fund opened new Vivani Medical Warrants positions in Q2 2018 and 2 closed out, a net change of -1 holder.
- The largest Vivani Medical Warrants seller in Q2 2018 was UBS Group, an estimated $5K sold.
Based on aggregated 13F filings for Q2 2018.